EUVIMEDEUVIMED entdecken
Open Access

ABT‑737 increases cisplatin sensitivity through the ROS‑ASK1‑JNK MAPK signaling axis in human ovarian cancer cisplatin‑resistant A2780/DDP cells

Xiaoning Li, Yumeng Guo, Zihan Xing, Tao Gong, Lijun Yang, Tao Yang, Bingmei Chang, Xiaoxia Wang, Baofeng Yu, Rui Guo

Oncology Reports · 2024

DOI: 10.3892/or.2024.8781 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, 2024. Verfasst von Xiaoning Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China. Hauptthemen laut MEDLINE: Cisplatin, Drug Resistance, Neoplasm, Ovarian Neoplasms, Reactive Oxygen Species. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinDrug Resistance, NeoplasmOvarian NeoplasmsReactive Oxygen SpeciesMAP Kinase Kinase Kinase 5Biphenyl CompoundsMAP Kinase Signaling SystemSulfonamidesNitrophenolsPiperazinesHumansFemaleCell Line, TumorApoptosisDrug SynergismGene Expression Regulation, NeoplasticAntineoplastic AgentsJNK Mitogen-Activated Protein Kinases

Stichwörter der Autor:innen

ABT‑737ROS‑ASK1‑JNK signaling axiscisplatin sensitivityovarian cancer

Substanzen

CisplatinReactive Oxygen SpeciesMAP Kinase Kinase Kinase 5Biphenyl CompoundsABT-737MAP3K5 protein, humanSulfonamidesNitrophenolsPiperazinesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
  • Department of Hematology, Linfen Central Hospital, Linfen, Shanxi 041099, P.R. China.
  • Department of Pharmacology, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.

Zitieren

APA

Li, X., Guo, Y., Xing, Z., Gong, T., Yang, L., Yang, T., Chang, B., Wang, X., Yu, B., & Guo, R. (2024). ABT‑737 increases cisplatin sensitivity through the ROS‑ASK1‑JNK MAPK signaling axis in human ovarian cancer cisplatin‑resistant A2780/DDP cells. Oncology Reports. https://doi.org/10.3892/or.2024.8781

Vancouver

Li X, Guo Y, Xing Z, Gong T, Yang L, Yang T, et al. ABT‑737 increases cisplatin sensitivity through the ROS‑ASK1‑JNK MAPK signaling axis in human ovarian cancer cisplatin‑resistant A2780/DDP cells. Oncology Reports. 2024. doi:10.3892/or.2024.8781

BibTeX
@article{Li2024,
  author = {Li, Xiaoning and Guo, Yumeng and Xing, Zihan and Gong, Tao and Yang, Lijun and Yang, Tao and Chang, Bingmei and Wang, Xiaoxia and Yu, Baofeng and Guo, Rui},
  title = {ABT‑737 increases cisplatin sensitivity through the ROS‑ASK1‑JNK MAPK signaling axis in human ovarian cancer cisplatin‑resistant A2780/DDP cells},
  journal = {Oncology Reports},
  year = {2024},
  doi = {10.3892/or.2024.8781}
}
Kostenlos starten →